Citadel Advisors - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$181,815
+76.7%
58,274
+160.0%
0.00%
Q2 2023$102,871
-86.5%
22,412
-85.4%
0.00%
Q1 2023$761,582
-93.5%
153,855
-92.8%
0.00%
-100.0%
Q4 2022$11,652,978
+52.6%
2,134,245
+81.7%
0.00%
+50.0%
Q3 2022$7,636,000
+20.2%
1,174,674
-12.6%
0.00%0.0%
Q2 2022$6,355,000
-39.3%
1,343,542
-10.2%
0.00%0.0%
Q1 2022$10,462,000
+5157.3%
1,496,760
+7560.4%
0.00%
Q4 2021$199,00019,5390.00%
Other shareholders
MAXCYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 372,000$4,542,0004.32%
Casdin Capital, LLC 13,971,334$170,590,0004.25%
Montanaro Asset Management Ltd 2,549,000$30,996,0003.74%
HARBERT FUND ADVISORS, INC. 724,856$8,850,0003.14%
Nine Ten Capital Management LLC 1,900,968$23,211,0002.48%
RIVER GLOBAL INVESTORS LLP 2,305,500$27,978,0002.17%
Vitruvian Partners LLP 3,330,000$40,659,0001.70%
Nicholas Investment Partners, LP 980,122$11,967,0000.87%
First Light Asset Management, LLC 994,670$12,145,0000.80%
AREX Capital Management, LP 126,968$1,550,0000.72%
View complete list of MAXCYTE INC shareholders